Antiviral Therapy

Papers
(The H4-Index of Antiviral Therapy is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Journey of remdesivir from the inhibition of hepatitis C virus to the treatment of COVID-1911
Tenofovir alafenamide fumarate8
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in p8
EDP-514 in healthy subjects and nucleos(t)ide reverse transcriptase inhibitor-suppressed patients with chronic hepatitis B7
Case study of hepatitis C virus control in Egypt: impact of access program6
The transformation of HIV therapy: One pill once a day5
The best backbone for HIV prevention, treatment, and elimination: Emtricitabine+tenofovir5
Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase in silico approach5
HIV drug resistance in the era of contemporary antiretroviral therapy: A clinical perspective5
Safety, tolerability, pharmacokinetics, and pharmacodynamics of oral JNJ-64794964, a TLR-7 agonist, in healthy adults5
The curing regimens of HCV: A SWOT analysis5
0.020357847213745